These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 10695937)

  • 1. Immunolocalizaiton of c-Myc and bcl-2 proto-oncogene products in gingival hyperplasia induced by nifedipine and phenytoin.
    Saito K; Mori S; Tanda N; Sakamoto S
    J Periodontol; 2000 Jan; 71(1):44-9. PubMed ID: 10695937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of p53 protein and Ki-67 antigen in gingival hyperplasia induced by nifedipine and phenytoin.
    Saito K; Mori S; Tanda N; Sakamoto S
    J Periodontol; 1999 Jun; 70(6):581-6. PubMed ID: 10397512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunolocalization of Bcl-2 oncoprotein in amlodipine-induced gingival overgrowth.
    Arunachalam LT; Rao S
    Indian J Dent Res; 2013; 24(2):255-60. PubMed ID: 23965458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical localization of transforming growth factor beta, basic fibroblast growth factor and heparan sulphate glycosaminoglycan in gingival hyperplasia induced by nifedipine and phenytoin.
    Saito K; Mori S; Iwakura M; Sakamoto S
    J Periodontal Res; 1996 Nov; 31(8):545-55. PubMed ID: 8971653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nifedipine induces gingival epithelial hyperplasia in rats through inhibition of apoptosis.
    Shimizu Y; Kataoka M; Seto H; Kido J; Nagata T
    J Periodontol; 2002 Aug; 73(8):861-7. PubMed ID: 12211494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical and histological comparative study of the effect of nifedipine and phenytion on human gingiva.
    Shoieb MA; Fathy LM; Abu-el-Dahab O; el-Sherbiny MM
    Egypt Dent J; 1993 Oct; 39(4):555-8. PubMed ID: 9588123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gingival hyperplasia caused by nifedipine. Histopathologic findings.
    Barak S; Engelberg IS; Hiss J
    J Periodontol; 1987 Sep; 58(9):639-42. PubMed ID: 3477631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nifedipine-induced gingival hyperplasia. A histochemical and ultrastructural study.
    Lucas RM; Howell LP; Wall BA
    J Periodontol; 1985 Apr; 56(4):211-5. PubMed ID: 3858503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gingival hyperplasia during treatment with nifedipine].
    Bokor-Bratić M; Vucković N; Selaković S
    Med Pregl; 1998; 51(9-10):445-8. PubMed ID: 9863337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nifedipine on the expression of bcl-2 protein in rat gingiva.
    Handajani J; Santoso AL; Haniastuti T; Utoro T; Sosroseno W
    Clin Oral Investig; 2003 Mar; 7(1):56-8. PubMed ID: 12673440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitotic activity of keratinocytes in nifedipine- and immunosuppressive medication-induced gingival overgrowth.
    Nurmenniemi PK; Pernu HE; Knuuttila ML
    J Periodontol; 2001 Feb; 72(2):167-73. PubMed ID: 11288789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of nifedipine-induced gingival hyperplasia.
    Nery EB; Edson RG; Lee KK; Pruthi VK; Watson J
    J Periodontol; 1995 Jul; 66(7):572-8. PubMed ID: 7562349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial hyperplasia in hydantoin induced hyperplastic and normal human gingiva.
    Larmas L; Paunio K
    Proc Finn Dent Soc; 1976 Oct; 72(5):177-9. PubMed ID: 981235
    [No Abstract]   [Full Text] [Related]  

  • 14. Density of CD1a-labeled Langerhans' cells in normal human gingiva and in nifedipine- and immunosuppressive medication-induced gingival overgrowth.
    Nurmenniemi PK; Pernu HE; Knuuttila ML
    J Periodontol; 1999 Jul; 70(7):752-6. PubMed ID: 10440636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of phenytoin by the gingiva of normal humans: the possible role of reactive metabolites of phenytoin in the initiation of gingival hyperplasia.
    Zhou LX; Pihlstrom B; Hardwick JP; Park SS; Wrighton SA; Holtzman JL
    Clin Pharmacol Ther; 1996 Aug; 60(2):191-8. PubMed ID: 8823237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nifedipine-induced gingival hyperplasia: a clinical and in vitro study.
    Nishikawa S; Tada H; Hamasaki A; Kasahara S; Kido J; Nagata T; Ishida H; Wakano Y
    J Periodontol; 1991 Jan; 62(1):30-5. PubMed ID: 2002429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced gingival hyperplasia and its management--a literature review.
    Botha PJ
    J Dent Assoc S Afr; 1997 Nov; 52(11):659-64. PubMed ID: 9589004
    [No Abstract]   [Full Text] [Related]  

  • 18. [Gingival hyperplasia due to diphenylhydantoin, cyclosporin A and nifedipine. A histopathological comparison].
    Silvestri E; Veraldi S; Piferi M; Sala F; Bencini L; Marini D
    Minerva Stomatol; 1988 Mar; 37(3):189-92. PubMed ID: 3166093
    [No Abstract]   [Full Text] [Related]  

  • 19. Regression of nifedipine-induced gingival hyperplasia following switch to a same class calcium channel blocker, isradipine.
    Westbrook P; Bednarczyk EM; Carlson M; Sheehan H; Bissada NF
    J Periodontol; 1997 Jul; 68(7):645-50. PubMed ID: 9249636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical distribution of extracellular matrix proteins as a diagnostic parameter in healthy and diseased gingiva.
    Romanos GE; Strub JR; Bernimoulin JP
    J Periodontol; 1993 Feb; 64(2):110-9. PubMed ID: 8433250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.